Cancer Research UK presents inaugural prizes at National Conference in Liverpool

The first ever Cancer Research UK prizes were presented this week at the National Cancer Research Institute Cancer Conference in Liverpool.

Eminent cancer researcher Professor Sir Richard Peto received the inaugural Cancer Research UK Lifetime Achievement prize. Professor Peto is a leading figure in both the prevention and treatment of cancer and helped run a pioneering 50 year study that further established the links between smoking and cancer.

The two recipients of the Future Leaders in Cancer Research Prize were Dr Peter Campbell at the Wellcome Trust Sanger Institute and Professor Jorge Reis-Filho at The Institute of Cancer Research. The Future Leaders in Cancer Research Prize recognises early career researchers who are already showing the potential to become world class leaders in their field.

A team from the University of Newcastle were awarded the Prize for Translational Cancer Research. The team has been at the forefront of the development of an exciting new class of drugs called PARP inhibitors that could treat a range of cancers including breast and ovarian.

The Cancer Research UK Prizes are three new prestigious awards that recognise world leading cancer researchers and the scientists of tomorrow.

Harpal Kumar, Cancer Research UK's chief executive, said: "We hope the prize winners will act as ambassadors for cancer research, spreading the word about the importance of their work and encouraging young scientists to consider cancer research as a career path. Cancer Research UK is committed to beating cancer by supporting the efforts of scientists, doctors and nurses whose hard work is making a real difference in increasing the number of people who survive the disease."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients